Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA expands TOFIDENCE (tocilizumab-bavi) indications to include CAR T-cell–induced CRS and pediatric COVID-19
2
FDA expands marstacimab (HYMPAVZI) approval to children ages 6–11 and hemophilia patients with inhibitors
3
ALYFTREK phase 3 data support pediatric CFTR modulator submissions
4
ADA 2026 data highlight pediatric outcomes and treatment satisfaction with Afrezza
5